Located in West Philadelphia in the heart of University City, our 500,000-square-foot, multi-story Gene Therapy Innovation Center will serve as a Roche center of excellence for gene therapy manufacturing globally. The new space will allow cross-functional teams to come together and work side by side to create a world where no life is limited by disease.
Our mission at Spark® Therapeutics is to unlock the power of gene therapy to accelerate healthcare transformation. We have built a fully integrated company, combining our proprietary adeno-associated viral (AAV) gene therapy platform with excellence in R&D, manufacturing and commercial operations. Find out more about how we strive to turn genes into medicines for patients with inherited diseases, including inherited retinal diseases (IRDs), liver-directed diseases such as hemophilia, and neurodegenerative diseases.
Spark® Therapeutics, Inc.
3737 Market Street
Philadelphia, PA 19104
Phone: 1-855-SPARKTX / +1 215-220-9300
N-SPK-US-700007-12
